What is TTC's health score?

TORO CO (TTC) has a TradeApes health score of 69 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TTC's estimated fair value?

Based on our 5-year discounted cash flow model, TORO CO's estimated fair value is $55.31 per share, representing a -36.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is TTC undervalued or overvalued?

Our model currently rates TTC as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for TTC... Refresh in a moment for the full analysis.

TORO CO (TTC)

Technology Overvalued low healthy

$87.21

Updated: 2026-06-06

TradeApes Score

Financial Strength

65 Healthy

Operating Trend

65 Healthy

Relative Value

73 Healthy

Capital Allocation

70 Healthy

Risk

80 Strong

Est. Fair Value $55.31

DCF Upside -36.6%

Sector Rank #1416 of 7804

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.